Wockhardt Ltd.

In News

Wockhardt Achieves Historic US FDA Nod For New Antibiotic, Shares Soar 19% As India Marks Pharma Breakthrough - MSN

MSN - Dec 02, 2025

Wockhardt Shares Extend Gains — Heres Why The Stock Has Been Rising - NDTV Profit

NDTV Profit - Dec 02, 2025

FDA accepts Wockhardt's NDA for breakthrough antibiotic Zaynich - Indian Pharma Post

Indian Pharma Post - Dec 02, 2025

Wockhardt Ltd dumps US generic pharma segment after losses, bets on antibiotics and insulin - The Economic Times

The Economic Times - Jul 11, 2025

Wockhardt shares rally 19% after US FDA accepts NDA for breakthrough antibiotic Zaynich - CNBC TV18

CNBC TV18 - Dec 01, 2025

Wockhardt’s Zaynich NDA gets USFDA acceptance: What India’s first NCE means for the company - Moneycontrol

Moneycontrol - Dec 02, 2025

Wockhardt soars 19% on huge volumes; here's why the pharma stock rose today - Business Standard

Business Standard - Dec 01, 2025

Wockhardt Sees Elevated Trading Activity Amidst Sector Outperformance - Markets Mojo

Markets Mojo - Dec 05, 2025

Wockhardt New Drug Application for Breakthrough antibiotic Zaynich accepted by USFDA - Medical Dialogues

Medical Dialogues - Dec 01, 2025

Wockhardt to exit US generic pharma segment, shut down 2 subsidiaries - The Indian Express

The Indian Express - Jul 11, 2025

USFDA accepts Wockhardt’s NDA for breakthrough antibiotic Zaynich - The Economic Times

The Economic Times - Dec 01, 2025

Wockhardt Eyes ‘Healthy Bottom Line’ In Coming Quarters Amid US Tariff Concerns - NDTV Profit

NDTV Profit - Aug 12, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment